Literature DB >> 17006749

A case of alpha-thalassemia-2 associated with pulmonary infarction.

Seiji Hayashi1, Hiroto Matsuoka, Teruo Harano, Keiko Harano, Hiroshi Nakahara, Isao Tachibana, Hiroshi Kida, Tomio Kawasaki, Shingo Kyotani, Yoshihiro Oka, Mitsunori Sakatani, Ichiro Kawase.   

Abstract

Pulmonary infarction is an entity of medical significance that develops concurrently in beta-thalassemia but not in alpha-thalassemia. The reason for this difference is yet to be elucidated. We have evaluated a 21-year-old male alpha-thalassemia-2 patient who had profound microcytic anemia and pulmonary infarction. Analysis of the alpha-globin gene revealed -alpha3.7/alpha alpha genotype. His mother also had the same heterozygous gene deletion, though she had neither anemia nor pulmonary infarction. Since the patient had no other predisposition to pulmonary infarction, it is suggested that there is a close etiologic relationship between morphologic abnormality of the erythrocytes caused by alpha-thalassemia-2 and development of pulmonary infarction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006749     DOI: 10.1007/s00408-005-2587-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  12 in total

Review 1.  The hypercoagulable state in thalassemia.

Authors:  Amiram Eldor; Eliezer A Rachmilewitz
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

2.  Thromboembolic complications in beta thalassemia major.

Authors:  J Michaeli; M Mittelman; D Grisaru; E A Rachmilewitz
Journal:  Acta Haematol       Date:  1992       Impact factor: 2.195

Review 3.  Oxidative denaturation of red blood cells in thalassemia.

Authors:  E Shinar; E A Rachmilewitz
Journal:  Semin Hematol       Date:  1990-01       Impact factor: 3.851

4.  Increased circulating platelet aggregates in thalassaemia.

Authors:  P Winichagoon; S Fucharoen; P Wasi
Journal:  Southeast Asian J Trop Med Public Health       Date:  1981-12       Impact factor: 0.267

Review 5.  Thalassemia.

Authors:  Alan R Cohen; Renzo Galanello; Dudley J Pennell; Melody J Cunningham; Elliott Vichinsky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

6.  Membrane phospholipid asymmetry in human thalassemia.

Authors:  F A Kuypers; J Yuan; R A Lewis; L M Snyder; C R Kiefer; A Bunyaratvej; S Fucharoen; L Ma; L Styles; K de Jong; S L Schrier
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

7.  A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood.

Authors:  A Eldor; R Durst; E Hy-Am; A Goldfarb; S Gillis; E A Rachmilewitz; A Abramov; J MacLouf; Y C Godefray; E De Raucourt; M C Guillin
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

8.  Thromboembolic complications in an asplenic HbE-beta-thalassaemia patient.

Authors:  A van Teunenbroek; F A Wijburg; J W ten Cate; W van den Berg; R S Weening
Journal:  Neth J Med       Date:  1989-10       Impact factor: 1.422

9.  Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.

Authors:  P Butthep; A Bunyaratvej; Y Funahara; H Kitaguchi; S Fucharoen; S Sato; N Bhamarapravati
Journal:  Southeast Asian J Trop Med Public Health       Date:  1997       Impact factor: 0.267

Review 10.  A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major.

Authors:  A Eldor; J Maclouf; F Lellouche; V Ben-Yashar; Y Barenholz; R Durst; E Hy-Am; A Goldfarb; E Rachmilewitz
Journal:  Southeast Asian J Trop Med Public Health       Date:  1993       Impact factor: 0.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.